about
Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.Staining of proteins for 2D SDS-PAGE using Coomassie Blue--speed versus sensitivity?Improved coomassie blue dye-based fast staining protocol for proteins separated by SDS-PAGEPlasma proteome changes associated with refractory cytopenia with multilineage dysplasiaPeripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndromePlasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups.Surface plasmon resonance: advances of label-free approaches in the analysis of biological samples.Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin.Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy.Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.Simplified platelet sample preparation for SDS-PAGE-based proteomic studies.The effect of the biological variability of samples on Coomassie blue dye based fast staining for SDS-PAGE in nonfixed gels.Acquired dysfibrinogenemia secondary to multiple myeloma.Proteomic analysis of plasma samples from acute coronary syndrome patients - the pilot studyN-Glycosylation of apolipoprotein A1 in cardiovascular diseasesComplete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfacesA novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen functionRetinol binding protein 4 plasma level in myelodysplastic syndrome subgroupsAbnormal fibrinogen Zlín (γThr21Ile) with missense mutation causing hypofibrinogenemia
P50
Q33748408-120BF7FD-8561-4C8C-B9C7-C9B1008B44DDQ34974324-FEFE1E46-D3CF-4E1B-A91C-F04E0A6C9E2AQ35054079-132D4ECE-5208-4C56-B286-DF273DA0B477Q35338994-78DEB865-5804-4496-A892-49BE68CDF51CQ35556586-F3F19BF0-3CF8-40C3-B756-56074567929CQ35574360-D26E15F6-6B49-4556-ACAF-92027986CE46Q36095679-8DD88E89-E382-40D9-80AB-E4BE343262CBQ38298338-1774D875-10C2-4C24-A806-74865D5BDF05Q38903700-F8FF34D2-970F-4476-AA5B-4112DE67AB2FQ41266897-C7241275-3444-40CD-9CA0-7E3012B1AEE7Q41952325-F83C5F1D-7C4E-4F38-A2AF-4658AE23F9BAQ42234130-F2140131-BA12-41D1-8DD9-03284E2DF469Q45397294-F16236E2-1922-476B-B439-2AD09439354DQ50225588-E3AF0959-1CF8-46CC-8FD5-B0B9148F303EQ50246351-7CDB8B9A-5853-4F69-B228-A86036C12A9AQ50426298-CF15E18D-3B87-49A2-BF2B-64BAE27FAD80Q55050726-E0B4DB6B-3FB3-440A-B44A-15E52D6DCECCQ83767217-6F55D17A-60EA-45D8-9D86-11B341F7AD0FQ85644714-67C86290-F0D6-4609-A4CB-869D95EDB5AAQ86079236-6245EAD9-E146-41A2-B316-1B0E8AEE990AQ86496380-6D757D47-0E23-4E4A-85D4-36B371D56BA0Q87252728-3DBDB0F3-BDC1-43B9-A778-21B7E40B8867Q87333366-9C0A49A6-2A9A-457A-A606-235D0FA9D3B3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pavel Májek
@ast
Pavel Májek
@en
Pavel Májek
@es
Pavel Májek
@nl
type
label
Pavel Májek
@ast
Pavel Májek
@en
Pavel Májek
@es
Pavel Májek
@nl
prefLabel
Pavel Májek
@ast
Pavel Májek
@en
Pavel Májek
@es
Pavel Májek
@nl
P106
P21
P31
P496
0000-0002-9946-3819